UNI-EN 48: Audited Consolidated Financial Statements for 2013 -CORRECTION
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| | UNI - EN REPORT No | 48 | / | 2014 | | ||||||
| Date of issue: | 2014-04-30 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Audited Consolidated Financial Statements for 2013 -CORRECTION | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 56 ust. 1 pkt 2 Ustawy o ofercie - informacje bieї№ce i okresowe | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| NOTIFICATION Sopharma AD (the “Company") notifies that due to a technical error, it republishes the consolidated financial statements of Sopharma AD for 2013. The audited consolidated financial statements of Sopharma AD for 2013 published today on 30 April 2014 shall be considered as the official consolidated annual financial statements of the company. Audited Consolidated Financial Statements for 2013 1. Audited Financial Statements 2. Notes to the Financial Statements 3. Management report 4 Independent Auditor's Report 5. Notification | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| SFARM GROUP CORRECTION.zip SFARM GROUP CORRECTION.zip | Audited Consolidated Financial Statements for 2013 -CORRECTION | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2014-04-30 | Ognian Donev | Executive director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 9.0 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
